(Z)-N-(4-Ethoxy-3-methylbenzo[d]thiazol-2(3H)-ylidene)-4-(morpholinosulfonyl)benzamide

Catalog No. :
ACORDL100
CAS No. :
1164529-17-2
Molecular Formula :
C21H23N3O5S2
Molecular Weight :
461.57

IUPAC Name:(Z)-N-(4-ethoxy-3-methylbenzo[d]thiazol-2(3H)-ylidene)-4-(morpholinosulfonyl)benzamide

(Z)-N-(4-Ethoxy-3-methylbenzo[d]thiazol-2(3H)-ylidene)-4-(morpholinosulfonyl)benzamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(Z)-N-(4-Ethoxy-3-methylbenzo[d]thiazol-2(3H)-ylidene)-4-(morpholinosulfonyl)benzamide
IUPAC Name(Z)-N-(4-ethoxy-3-methylbenzo[d]thiazol-2(3H)-ylidene)-4-(morpholinosulfonyl)benzamide
Molecular FormulaC21H23N3O5S2
Molecular Weight461.57
SMILESCCOC1=C2C(=CC=C1)S/C(=N\C(=O)C1=CC=C(S(=O)(=O)N3CCOCC3)C=C1)N2C
InChI KeyINGPLZDGPPEVIG-DQRAZIAOSA-N
SynonymBenzamide, N-(4-ethoxy-3-methyl-2(3H)-benzothiazolylidene)-4-(4-morpholinylsulfonyl)-, [N(Z)]-
CAS No.1164529-17-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACORDL100 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACKQAL872 route compound structure diagram
    ACKQAL872654682-86-7 In Stock
  4. Then
  5. ACORDL100 route product structure diagram
    ACORDL1001164529-17-2
Inquiry

2. ACORDL100 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACMJDI408 route compound structure diagram
    ACMJDI40810252-82-1 In Stock
  4. Then
  5. ACORDL100 route product structure diagram
    ACORDL1001164529-17-2
Inquiry

Comments (0)